Laurie A. Miller - Sep 17, 2021 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
SVP, Human Resources
Signature
/s/ Michelle Basil, attorney-in-fact for Ms. Miller
Stock symbol
HAE
Transactions as of
Sep 17, 2021
Transactions value $
$0
Form type
4
Date filed
9/21/2021, 09:20 PM
Previous filing
Sep 21, 2021
Next filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Award +2.85K +39.38% 10.1K Sep 17, 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Equity Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.
F2 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
F3 This includes unvested RSUs previously reported.